MBX

MBX Biosciences, Inc. Common Stock
MBX

Overview Fund Activity

63 hedge funds and large institutions have $606M invested in MBX Biosciences, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
+19
Holders Change %
+43.18%
% of All Funds
0.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
34
Increased
11
Reduced
8
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
$13.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
$12.4M
3
DCM
Driehaus Capital Management
Illinois
$29.2M
4
Geode Capital Management
Geode Capital Management
Massachusetts
$4.9M
5
PHP
Parkman Healthcare Partners
Connecticut
$3.13M

Top Sellers

1
Millennium Management
Millennium Management
New York
$6.15M
2
Franklin Resources
Franklin Resources
California
$6.81M
3
MIM
Monashee Investment Management
Massachusetts
$0
4
MS
Maven Securities
Jersey
$0
5
SC
Stempoint Capital
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PAS
76
Point72 Asia (Singapore)
Singapore
– -$278K -10,706 Closed
CM
77
Capula Management
Cayman Islands
– -$217K -8,362 Closed
ACM
78
Aster Capital Management
United Arab Emirates
– -$47K -1,810 Closed
1 2 3
4